Estradiol causes the rapid accumulation of cAMP in human prostate.
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Androgens are widely acknowledged to be central to the pathogenesis of benign prostatic hypertrophy (BPH). However, BPH increases in prevalence as men age, at precisely the stage of life when plasma androgens are decreasing. The decrease in total plasma androgens is amplified by an age-related increase in plasma sex hormone-binding globulin (SHBG) that results in a relatively greater decrease in free androgens than in total androgens. In addition, estrogens have long been suspected to be important in BPH, but a direct effect on the human prostate has never been demonstrated. We present data that are consistent with a role for estradiol, and for a decrease in androgens and an increase in SHBG, in the pathogenesis of BPH. We show that estradiol, but not dihydrotestosterone, acts in concert with SHBG to produce an 8-fold increase in intracellular cAMP in human BPH tissue. This increase is not blocked by an antiestrogen and is not provoked by an estrogen (diethylstilbestrol) that does not bind to SHBG, thus excluding the classic estrogen receptor as being operative in these events. Conversely, dihydrotestosterone, which blocks the binding of estradiol to SHBG, completely negates the effect of estradiol. Finally, we demonstrate that the SHBG-steroid-responsive second-messenger system is primarily localized to the prostatic stromal cells and not to the prostatic epithelial cells. Thus, we have shown a cell-specific, powerful, nontranscriptional effect of estradiol on the human prostate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cooke, R. R., McIntosh, J. E. A., & McIntosh, R. P. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb01769.x · Cited by 95
Cited by
Filardo, E. J., Quinn, J. A., Frackelton, A. R., & Bland, K. I. (2002) · Molecular Endocrinology · doi:10.1210/me.16.1.70 · Cited by 904
Estrogen Receptor α Rapidly Activates the IGF-1 Receptor Pathway
Kahlert, S., Nuedling, S., van Eickels, M., Vetter, H., Meyer, R., & Grohé, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910345199 · Cited by 474
Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binding protein
Safadi, F. F., Thornton, P., Magiera, H., Hollis, B. W., Gentile, M., Haddad, J. G., Liebhaber, S. A., & Cooke, N. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5244 · Cited by 402
Danzo, B. J. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105294 · Cited by 352
Zhou, Y., Watters, J. J., & Dorsa, D. M. (1996) · Endocrinology · doi:10.1210/en.137.5.2163 · Cited by 290
Mark, M. R., Chen, J., Hammonds, R. G., Sadick, M., & Godowsk, P. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9785 · Cited by 206
Sex hormone-binding globulin is synthesized in target cells
Kahn, S., Hryb, D., Nakhla, A., Romas, N., & Rosner, W. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750113 · Cited by 199
Self-citationSex hormone-binding globulin mediates steroid hormone signal transduction at the plasma membrane
Rosner, W., Hryb, D. J., Khan, M. S., Nakhla, A. M., & Romas, N. A. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(99)00070-9 · Cited by 195
“However, in non-malignant prostatic tissue, from both humans and dogs, not only is DHT±SHBG inactive in causing increases in cAMP, but it inhibits the activation of SHBG±RSHBG by estradiol [10,11].”
BackgroundSelf-citationKanda, N., & Watanabe, S. (2003) · Journal of Investigative Dermatology · doi:10.1111/j.1523-1747.2003.12617.x · Cited by 166
Tang, W.-Y., Morey, L. M., Cheung, Y. Y., Birch, L., Prins, G. S., & Ho, S.-M. (2012) · Endocrinology · doi:10.1210/en.2011-1308 · Cited by 164
Zhang, M., Magit, D., & Sager, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5673 · Cited by 158
Mid‐life adiposity factors relate to blood–brain barrier integrity in late life
Gustafson, D. R., Karlsson, C., Skoog, I., Rosengren, L., Lissner, L., & Blennow, K. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01869.x · Cited by 107
Yamazaki, H., Kushiyama, A., Sakoda, H., Fujishiro, M., Yamamotoya, T., Nakatsu, Y., Kikuchi, T., Kaneko, S., Tanaka, H., & Asano, T. (2018) · Mediators of Inflammation · doi:10.1155/2018/3062319 · Cited by 86
“The increased intracellular cAMP levels in several cells [14, 16, 17] suggest the involvement of G protein and adenylate cyclase, though neither of these responses was observed in our present experiments.”
BackgroundResultWang, C. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1462 · Cited by 54
Metadata
- Authors
- Nakhla, A. M., Khan, M. S., Romas, N. P., & Rosner, W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1994-06-07
- Volume
- 91
- Issue
- 12
- Pages
- 5402-5405
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2029625187
- Cited by
- 131
- References
- 1
- FWCI
- 12.16
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.